Intensity Therapeutics, Inc Common stock
Yahoo Finance • 11 days ago
Intensity Therapeutics, Inc. to Present INVINCIBLE-4 Neoadjuvant Triple-Negative Breast Cancer Study Data for the First Seven (7) Patients After INT230-6 Treatment (Cohort A) in an ePoster Presentation at the European Society of Medical Oncology (ESMO) Meeting
Pathological complete response (pCR) achieved in the breast (ypT0/Tis) and affected lymph nodes (ypN0) in 5 out of 7 patients (71%; 95% CI 29-96%) in the INT230-6 plus standard-of-care cohort No invasive breast cancer cells were detected i... Full story
Yahoo Finance • 3 months ago
Intensity therapeutics targets INVINCIBLE-4 enrollment completion by end of 2027 while seeking $30M to finish INVINCIBLE-3
Earnings Call Insights: Intensity Therapeutics (INTS) Q2 2026 MANAGEMENT VIEW * "It is my pleasure to provide the latest update of our company's progress in the INVINCIBLE-3 and INVINCIBLE-4 studies, our business development activities... Full story
Yahoo Finance • last year
Trending tickers: Apple, Amazon, Netflix, Reddit and Intensity Therapeutics
Apple (AAPL) Shares in Apple (AAPL) were higher in pre-market trading following the tech giant's fiscal fourth-quarter results, which exceeded Wall Street's expectations. Apple posted total revenue of $102.5bn (£77bn) for the quarter, ma... Full story
Yahoo Finance • last year
Stay updated with the stocks that are on the move in today's after-hours session.
Discover the top movers in Wednesday's after-hours session and stay informed about the post-market dynamics. [postmarket] AFTER HOURS GAINERS TICKER CHANGE COMMENT THAR [https://www.chartmill.com/stock/quote/THAR/profile] 1... Full story
Yahoo Finance • last year
Intensity Therapeutics regains compliance with Nasdaq requirement
Intensity Therapeutics (NASDAQ:INTS [https://seekingalpha.com/symbol/INTS]) said [https://seekingalpha.com/pr/20197325-intensity-therapeutics-inc-regains-compliance-with-nasdaqs-minimum-stockholders-equity] on Tuesday that the biotechnolog... Full story
Yahoo Finance • last year
Intensify Therapeutics slumps 27%, prices $2M stock offering
* Intensity Therapeutics (NASDAQ:INTS [https://seekingalpha.com/symbol/INTS]) stock price slumped 27% on Wednesday during after market hours of trading as it priced [https://seekingalpha.com/pr/20134342-intensity-therapeutics-inc-announc... Full story